Diabetes pioneer to deliver 7th Presidential Distinguished Lecture Oct. 24

October 15, 2008

Francisco G. Cigarroa, M.D., president of The University of Texas Health Science Center at San Antonio, invites the university community and the public to the Seventh Annual Presidential Distinguished Lecture, this year presented by C. Ronald Kahn, M.D., of the Joslin Diabetes Center in Boston.

Drug lowers conversion to type 2 diabetes by 81% in multicenter research study

June 12, 2008

In a research study of hundreds of patients facing the prospect of developing type 2 diabetes, the oral drug pioglitazone (brand name: Actos®) reduced the rate of conversion to the disease by 81 percent in the active therapy group compared to those taking a placebo, the study leader, Ralph A. DeFronzo, M.D., reported June 9 during the 68th Scientific Sessions of the American Diabetes Association in San Francisco.